An endogenous metabolite of dopamine, 3,4-dihydroxyphenylethanol, acts as a unique cytoprotective agent against oxidative stress-induced injury

Free Radical Biology and Medicine

Volumn 36, Issue 5, 2004, Pages 555-564

  Hashimoto, Tsuneichi ^a   Ibi, Masakazu ^a   Matsuno, Kuniharu ^a   Nakashima, Shingo ^a   Tanigawa, Toru ^a   Yoshikawa, Toshikazu ^a   Yabe Nishimura, Chihiro ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

3,4 Dihydroxyphenylethanol; Catalase; Dopamine; Free radicals; Olive oil; Oxidative stress; PC12 cells; Reactive oxygen species

Indexed keywords

AMITROLE; ANILINE DERIVATIVE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; HYDROXYTYROSOL; IRON; LACTATE DEHYDROGENASE; SUPEROXIDE;

ANIMAL CELL; ARTICLE; ASSAY; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; FENTON REACTION; NONHUMAN; OXIDATIVE STRESS; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; SCAVENGING SYSTEM; SPIN TRAPPING;

EID: 1242286940     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2003.12.003     Document Type: Article

References (36)

1. Satsman E.R., Berlett B.S. Fenton chemistry: amino acid oxidation. J. Biol. Chem. 266:1991;1720-17211.
2. Visioli F., Galli C. The effect of minor constituents of olive oil on cardiovascular diseases: new findings. Nutr. Rev. 56:1998;142-147.
3. Hertog M.G.L., Feskens E.J.M., Hollman P.C., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 342:1993;1007-1011.
4. Hertog M.G.L., Sweetnam P.M., Fehily A.M., Elwood P., Kromhout D. Antioxidants, flavonols and ischemic heart diseases in Welsh population of men: the Caerphilly Study. Am. J. Clin. Nutr. 65:1997;1489-1494.
5. Hertog M.G.L., Kromhout D., Aravanis C., Blackburn H., Buzina R., Fidanza F., Giampaoli S., Jansen A., Menotti A., Nedeljkovic S. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch. Intern. Med. 155:1995;381-386.
6. Hertog M.G.L., Feskens E.J.M., Hollman P.C.H. Dietary flavonoid and cancer risk in the Zutphen Elderly Study. Nutr. Cancer. 22:1994;175-184.
7. Hussain S.P., Hofseth L.J., Harris C.C. Radical causes of cancer. Nat. Rev. Cancer. 3:2003;276-285.
8. Grignaffini P., Roma P., Galli C., Catapano A.L. Protection of low-density lipoprotein from oxidation by 3,4-dihydroxyphenylethanol. Lancet. 343:1994;1296-1297.
9. Visioli F., Bellome G., Galli C. Free radical-scavenging properties of olive oil polyphenols. Biochem. Biophys. Res. Commun. 247:1998;60-64.
10. Manna C., Galletti P., Cucciolla V., Moltedo C., Leone A., Zappia V. The protective effect of the olive oil polyphenol (3,4-dihydroxyphnyl)-ethanol counteracts reactive oxygen metabolite-induced cytotoxicity in Caco-2 cells. J. Nutr. 127:1997;286-292.
11. Manna C., Galletti P., Cucciolla V., Montedoro G., Zappia V. Olive oil hydroxytyrosol protects human erythrocytes against oxidative stress. J. Nutr. Biochem. 10:1999;159-165.
12. Visioli F., Galli C., Plasmati E., Viappiani S., Hernandes A., Colombo C., Sala A. Olive phenol hydroxytyrosol prevents passive smoking-induced oxidative stress. Circulation. 102:2000;2169-2171.
13. Edwards D.V., Rizk M. Conversion of 3,4-dihydroxyphenylalanine and deuterated 3,4-dihydroxyphenylalanine to alcoholic metabolites of catecholamines in rat brain. J. Neurochem. 36:1981;164-1647.
14. Xu C.L., Sim K. Reduction of dihydroxyphenylacetic acid by a novel enzyme in the rat brain. Biochem. Pharmacol. 50:1995;1333-1337.
15. Hinshow D.B., Miller M.T., Omann G.M., Beals T.F., Hyslop P.A. A cellular model of oxidant-mediated neuronal injury. Brain Res. 615:1993;13-26.
16. Jenner P., Onanow C.W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology. 47:1996;161-170.
17. Belh C., Davia J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β-amyloid protein toxicity. Cell. 77:1994;817-827.
18. Smith M.A., Rottkamp C.A., Nunomura A., Raina A.K., Perry P.G. Oxidative stress in Alzheimer's disease. Biochim. Biophys. Acta. 1502:2000;139-144.
19. Rosen D., Siddique T., Patterson D., Figlewicz D., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J., Deng H. Mutations on Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis. Nature. 363:1993;59-62.
20. Shaw C., Enayat Z., Chioza B., Al-Chalabi A., Radunovic A., Powell J., Leigh P. Mutation in all five exons of SOD-l may cause ALS. Ann. Neurol. 43:1998;390-394.
21. Gay R.J., McComb R.B., Bowers G.N. Optimum reaction conditions for human lactate dehydrogenase isozymes as they affect total lactate dehydrogenase activity. Clin. Chem. 14:1968;740-753.
22. Aebi H. Catalase in vitro. Methods Enzymol. 105:1984;121-126.
23. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70:1967;158-169.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
25. Seo H.G., Nishinaka T., Yabe-Nishimura C. Nitric oxide up regulates aldose reductase expression in rat vascular smooth muscle cells: a potential role for aldose reductase in vascular remodeling. Mol. Pharmacol. 57:2000;709-717.
26. Honegger C.G., Langermann H., Krenger W., Kempf A. Liquid chromatographic determination of common water-soluble antioxidants in biological samples. J. Chromatogr. 187:1989;463-468.
27. Bors W., Michel C., Saran M. On the nature of biochemically generated hydroxyl radical: studies using the bleaching of p-nitrosodimethylaniline as a direct assay method. Eur. J. Biochem. 95:1979;621-627.
28. Ando T., Yoshikawa T., Tanigawa T., Kohno M., Yoshida N., Kondo M. Quantification of singlet oxygen from hematoporphyrin derivative by electron spin resonance. Life Sci. 61:1997;1953-1959.
29. Walkinshaw G., Waters C.M. Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA: implication for the treatment of Parkinson's disease. J Clin. Invest. 95:1995;2458-2464.
30. Cheng N., Maeda T., Kume T., Kaneko S., Kochiyama H., Akaike A., Goshima Y., Misu Y. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Brain Res. 743:1996;278-283.
31. MacManus J.P., Linnik M.D. Gene expression induced by cerebral ischemia: an apoptotic perspective. J. Cereb. Blood Flow Metab. 17:1997;815-832.
32. Zhang H.-Y., Tang X.-C. Huperzine B, a novel acetylcholinesterase inhibitor, attenuates hydrogenperoxide induced injury in PC12 cells. Neurosci. Lett. 292:2000;41-44.
33. Jackson G.R., Apffel L., Werrbach-Perez K., Perezpolo J.R. Role of nerve growth factor in oxidant-antioxidant balance and neuronal injury. J. Neurosci. Res. 25:1990;360-368.
34. Rordanz E., Schmuc G., Ohler S., Kahl R. The influence of oxidative stress on catalase and MnSOD gene transcription in astrocytes. Brain Res. 900:2001;128-136.
35. Spencer J., Jenner A., Butler J., Aruoma O., Dexter D.T., Jenner P., Halliwell B. Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's disease. Free Radic. Res. 24:1996;95-105.
36. Mentasti E., Pelizzetti E. Reaction between iron(II1) and catechol (o-dihydroxybenzene): Part 1. Equilibria and kinetics of complex formation in aqueous acid solution. J. Chem. Soc. Dalton Trans. 1973;2605-2614.